chevron_leftBack
As of 24 April 2025, Sun Pharmaceutical Industries Ltd. has a market cap of $49.13B USD, ranking #405 globally and #14 in India. It ranks #39 in the Healthcare sector, and #3 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$49.13BUSD
4.19T INR
Enterprise Value
$47.01BUSD
4.02T INR
Revenue (TTM)
$6.05BUSD
516.03B INR
EBITDA (TTM)
$1.71BUSD
146.44B INR
Net Income (TTM)
$1.34BUSD
114.34B INR
EBITDA Margin
28%
Profit Margin
22%
PE Ratio
36.6
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Dilip Shanghvi
open_in_new
Employees
43,000
Founded
1983
Website
sunpharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 2.4% | 3.5% | -2.1% | -0.9% | -7.9% | 15% |
Upcoming Earnings
Earnings Date
Thu, May 22
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SUNPHARMA
Sun Pharmaceuticals Industries Ltd
ISIN: INE044A01036
Shares Out.:
Shares Outstanding:
2.399B1
Shares Float:
990.876M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.79K INR | |
|
524715
(SUNPHARMA)
Sun Pharmaceuticals Industries Ltd
ISIN: INE044A01036
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.75K INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and antiretrovirals medications, as well as over-the-counter products. The company was founded in 1983 and is headquartered in Mumbai, India.
